A Turn in Tide, Europe's New Deal - Research Report on Achillion Pharmaceuticals, Inc. and Idenix Pharmaceuticals, Inc.
November 07 2011 - 9:00AM
Marketwired
Today, www.WorldStreetFundamentals.com released its industry report
highlighting Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) and
Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX). Full fundamental and
technical analysis is available at
www.WorldStreetFundamentals.com/Reports.php?id=ACHN+IDIX.
Markets are starting to step in the right direction, with the
European Financial Stability Facility (EFSF) increasing from $600
billion to $1.4 trillion, a significant move to strengthen the
safety net in place for Europe's most troubled countries.
It is likely China and the IMF will contribute to the bailout
fund, with Greece alone receiving $180 billion in fresh aid. The
remainder of Greece's obligations were halved in the process, with
private bondholders of Greek debt settling at 50% -- allowing banks
to recapitalize at a healthy 9% reserve and bring Greece's debt
burden down to 120% of GDP by 2020.
An important consideration is political commitment to this road
map and probability of ongoing support for European Central Bank
(ECB)'s recent deal. Currently the global community appears to be
on point with ECB's initiative, an outlook that should be
sufficient to support markets around current levels.
World Street Fundamentals has highlighted Achillion
Pharmaceuticals, Inc. for its current position within the
healthcare industry. Achillion Pharmaceuticals, Inc. is a
biopharmaceutical company focused on the discovery, development and
commercialization of treatments for infectious diseases. The entire
report on Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) is
available here:
www.WorldStreetFundamentals.com/Report.php?id=ACHN.
World Street has featured Idenix Pharmaceuticals, Inc. for its
development within the healthcare industry. Idenix Pharmaceuticals,
Inc. (Idenix) is a biopharmaceutical company engaged in the
discovery and development of drugs for the treatment of human viral
diseases with operations in the United States and Europe. The
Company's research and development focus is on the treatment of
hepatitis C virus (HCV). The entire report on Idenix
Pharmaceuticals, Inc. (NASDAQ: IDIX) is available here:
www.WorldStreetFundamentals.com/Report.php?id=IDIX.
About World Street World Street Fundamentals is an online portal
for professionals, investors and new-comers to the markets to find
in depth comprehensive research and research tools to help guide
you through the ever changing financial markets.
Contact: Adam Redford Email Contact
www.WorldStreetFundamentals.com
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024